156 related articles for article (PubMed ID: 10986361)
1. Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2.
Lawston J; Borella A; Robinson JK; Whitaker-Azmitia PM
Brain Res; 2000 Sep; 877(2):407-10. PubMed ID: 10986361
[TBL] [Abstract][Full Text] [Related]
2. Chronic cannabinoid agonist (WIN 55,212-2) exposure alters hippocampal dentate gyrus spine density in adult rats.
Candelaria-Cook FT; Hamilton DA
Brain Res; 2014 Jan; 1542():104-10. PubMed ID: 24183783
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids alter spontaneous firing, bursting, and cell synchrony of hippocampal principal cells.
Goonawardena AV; Riedel G; Hampson RE
Hippocampus; 2011 May; 21(5):520-31. PubMed ID: 20101600
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons.
Hampson RE; Simeral JD; Kelly EJ; Deadwyler SA
Hippocampus; 2003; 13(5):543-56. PubMed ID: 12921345
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus.
Kirby MT; Hampson RE; Deadwyler SA
Brain Res; 2000 Apr; 863(1-2):120-31. PubMed ID: 10773200
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
[TBL] [Abstract][Full Text] [Related]
8. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.
Beinfeld MC; Connolly K
Neurosci Lett; 2001 Mar; 301(1):69-71. PubMed ID: 11239718
[TBL] [Abstract][Full Text] [Related]
9. The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit.
Zubedat S; Akirav I
Eur Neuropsychopharmacol; 2017 Apr; 27(4):336-349. PubMed ID: 28131675
[TBL] [Abstract][Full Text] [Related]
10. WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids.
Barna I; Soproni K; Arszovszki A; Csabai K; Haller J
Behav Pharmacol; 2007 Sep; 18(5-6):515-20. PubMed ID: 17762520
[TBL] [Abstract][Full Text] [Related]
11. Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2.
Nallapaneni A; Liu J; Karanth S; Pope C
Toxicology; 2006 Oct; 227(1-2):173-83. PubMed ID: 16956707
[TBL] [Abstract][Full Text] [Related]
12. [The synthetic cannabinoid analog WIN 55,212-2 potentiates the amplitudes of glycine-activated currents].
Iatsenko NM; Tsintsadze TSh; Lozova NO
Fiziol Zh (1994); 2007; 53(3):31-7. PubMed ID: 17725041
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain.
Marchalant Y; Brothers HM; Wenk GL
Mol Psychiatry; 2009 Dec; 14(12):1068-9. PubMed ID: 19920834
[No Abstract] [Full Text] [Related]
14. Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal- and amygdala-dependent memory and plasticity.
Shoshan N; Segev A; Abush H; Mizrachi Zer-Aviv T; Akirav I
Hippocampus; 2017 Oct; 27(10):1093-1109. PubMed ID: 28667676
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
Sim LJ; Hampson RE; Deadwyler SA; Childers SR
J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
[TBL] [Abstract][Full Text] [Related]
16. Effects of Win 55,212-2 on hippocampal CA1 long-term potentiation in experiments controlled for basal glutamatergic synaptic transmission.
Diana G; Pieri M; Valentini G
Eur J Pharmacol; 2002 Oct; 453(2-3):251-4. PubMed ID: 12398912
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids, hippocampal function and memory.
Hampson RE; Deadwyler SA
Life Sci; 1999; 65(6-7):715-23. PubMed ID: 10462072
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers.
Hájos N; Freund TF
Neuropharmacology; 2002 Sep; 43(4):503-10. PubMed ID: 12367597
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
20. Subicular lesions cause dendritic atrophy in CA1 and CA3 pyramidal neurons of the rat hippocampus.
Shankaranarayana Rao BS; Govindaiah ; Laxmi TR; Meti BL; Raju TR
Neuroscience; 2001; 102(2):319-27. PubMed ID: 11166118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
